CLINICAL_TRIALS
trial_result
· 2022-11-04
Clinical Trial Update: A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial evaluating safety and efficacy of etrasimod for moderate-to-severe atopic dermatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Arena Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2022-11-04